19 Aralık 2015 Cumartesi

Ozon 2015 ilk yarı yayınları

Antifungal action of ozone against Colletotrichum gloeosporioides and control of papaya anthracnose

Abstract

To elucidate the antifungal action and possible responses of ozone on the fungus, the effect of gaseous ozone on the germination of conidia of Colletotrichum gloeosporioides, anthracnose control in papaya and mitochondrial degradation in spores was studied. Ozone treatment appeared to suppress the growth of C. gloeosporioides in the in vivo study. Ozone also induced the generation of reactive oxygen species (ROS) in the fungal spores as shown by the oxidant-sensitive stain 2,7-dichlorodihydrofluorescein diacetate. Degradation of mitochondria in the spores was observed after 24 h of ozone treatment at 3.5 and 5.0 μL/L using transmission electron microscopy. Abnormalities in the ultrastructure of spores treated with 5.0 μL/L ozone included an increase in mitochondrial degradation, cytoplasmic disintegration and plasmolysis. These results suggest that mitochondria of the spores could be one of the mechanisms involved in the antifungal activity of ozone responses against C. gloeosporioides.

İlgili yayında ozon gazının mantarlar üzerine olan mitokondrial bozulma ve hücre sitoplazmasında bozulma 








Mevcut yazılı metin bilgilendirme amaçlıdır. Bilimsel verilerden elde edilmiş bilgilerdir. Konu hakkında uzman kişiler tarafından yönlendirilmeniz ve tedaviye yönelik işlemleri bir hekim kontrolünde uygulamanız veya uygulatmanız önerilir.Ankara ozon , ozon ankara , alternatif kanser tedavisi , dmso , integratif tıp , akupunktur ,

Intravenous Vitamin C (Ascorbic Acid) Infusion in Oncologic Treatment

Administering High-Dose Ascorbic Acid* by Injection in Cancer/Tumor Therapy

from Revisiting Vitamin C and Cancer by Neil H. Riordan PA-C, MS, Managing Director, ITL Clinic
Introduction by Healing Cancer Naturally © 2007
There seem to be a number of apparently permanent cancer cures effected or catalyzed by so-called alternative cancer treatments such as intravenous vitamin C infusion, of which the following report is an example: “[M]y Mother had breast cancer 34 years ago with multiple lymph node involvement. She had surgery and then IV laetrile and IV Vitamin C and has been free of breast cancer since.”
While such healings are wonderful and worthwhile reporting, we cannot be sure whether other factors didn’t play a decisive role as well. Conceivably, the cancer diagnosis in itself roused great determination and inner resources in the person concerned, leading to simple or multiple beneficial changes in their inner and outer circumstances and the way they lived their life on the physical, emotional, mental and spiritual plane.
Healing Cancer Naturally generally encourages its readers to go for a holistic approach, i.e. to aim to achieve healing - particularly of a permanent and “all-round” nature - by exploring and reestablishing health on all levels of human existence. You will find ample material and pointers to achieve just that on the several hundreds of pages of this site, particularly in Emotions & Cancer HealingEnergeticsNutritionHealing & Your Mind and Spirituality.
George Williams was 70 years old in 1986. That was the year he learned he had kidney cancer. The cancer had spread to his liver and the lymph nodes in his chest. His oncologist told him he could give him chemotherapy and radiation but it wouldn't likely help. The doctor suggested George get his affairs in order.
George had heard about the work of Linus Pauling and some Scottish doctors on the effects of megadoses of vitamin C on cancer. He then visited the only doctor in Wichita, Kansas who treated people with megadoses of vitamins, my father, Hugh Riordan, M.D. My father told George that he would give him injections of vitamin C but didn't know if it would help. George received 30 grams (30,000 milligrams) of vitamin C twice a week for six weeks. X-rays six weeks later showed a marked decrease in the size of the tumors. George continued the injections. Six months later there was no evidence of cancer. Mr. Williams lived a relatively healthy life for another 14 years and died a few years ago of congestive heart failure at the age of 84.
In the Fall of 1994, a 73 year-old farmer from Western Kansas was diagnosed with wide-spread non-Hodgkin's lymphoma. Biopsies and CT-scans showed he had cancer in all the lymph nodes from his chest up. He was treated with chemotherapy for 8 months resulting in a remission. In July, 1997 he began losing weight (30 lbs). He returned to his oncologist and a CT-scan at that time showed recurrence. He was placed on chemotherapy in September, 1997. In December, 1997 with no change in the cancer, his immune system was so depressed he developed a case of Shingles and the chemotherapy was stopped. I first saw this gentleman in March, 1998. He was given vitamin C injections 50 grams (50,000 millligrams) two times per week. Three months after beginning vitamin C therapy a CT-scan showed no evidence of cancer. Another CT-scan in February, 1999 was also clear and he was declared to be in complete remission by his oncologist.
Given the results seen clinically as described in the cases above, my father and I went on to perform research on the effects of vitamin C on the immune system and tumor cells. The two major conclusions coming from our research were 1) people with cancer require much more vitamin C than healthy people; and 2) vitamin C in high doses (given through the vein) can act similar to chemotherapy without the side effects. Our latest article was published in the British Journal of Cancer.
It's a good thing that neither my father nor George listened to the negative reports on vitamin C and cancer that came out of the Mayo Clinic several years before he began treatment. Those two clinical tests in Minnesota found the vitamin did not alter the course of disease and the notion was abandoned-it was essentially rejected as a cancer treatment at that time.
Two recent articles in the Canadian Medical Association Journal suggest the Mayo research was flawed and the scientists were biased against the use of "alternative" cancer treatments.
The author of one of the articles, Dr. John Hoffer, a professor of medicine at McGill University, says, "In 1971, even saying that vitamin C could be useful was so outlandish that a conversation would stop between scientists and physicians."
"What's changed now is ... a commitment on the part of agencies to study alternative cancer therapies."
Dr. Hoffer said his own speculation is the Mayo researchers "wanted a quick and decisive way to disprove the treatment."
In May of 1999, vitamin C researchers, including my father and I attended a closed-door research workshop in Montreal. There we began re-examining the methods used to test high-dose vitamin C against cancer. Dr. Hoffer attended the meeting, as did Dr. Mark Levine, a molecular scientist at the National Institutes of Health. One of the conclusions of the workshop was that the Mayo Clinic treatments were too short, and the vitamin C was given by mouth, not by injection. If given by mouth the vitamin is not as well absorbed and blood levels do not reach a concentration high enough to disable tumor cells.
Dr. Levine in the other Canadian Journal article wrote, "We should rigorously explore the anti-cancer effects of vitamin C, when administered intravenously at high doses, in patients with well-documented cancer."
We routinely give large doses of vitamin C to people with cancer at the ITL Clinic. In addition to its anti-tumor effects vitamin C has side "benefits," as opposed to adverse side effects seen with other cancer treatments. The side benefits include an increased sense of well-being, decreased pain, enhanced immune system and stronger collagen-the glue that prevents cancer cells from spreading.
Many people who come to our clinic are taking chemotherapy and/or radiation. We find that people tolerate these standard treatments much better when they also get high dose vitamin C. One patient comes to mind, Richard, a 54 year old businessman was diagnosed with stage IV colon cancer 5 years ago. He was put on chemotherapy and at the same time I started him on vitamin C infusions 2-3 times per week. He sailed through the chemotherapy without any symptoms. After 11 months of treatment he went on a two-week trip to Florida. He was able to get his chemotherapy from a doctor there, but not the vitamin C. By the end of the trip he was getting typical side effects from the chemotherapy-most prominently mouth and throat ulcers. One week after getting back on the vitamin C his ulcers healed. Richard remains alive and well today.
Also compare this anecdotal report on Vitamin C helping prevent negative radiation treatment symptoms.
Occasionally people who take vitamin C experience miraculous results, however it is not a cancer cure. As part of a comprehensive cancer treatment program vitamin C is a powerful tool to help people have stronger immune systems, an increased quality of life, and increased chances of surviving their disease.
"Twelve years ago, we used infusions of 30 grams of intravenous ascorbic acid, twice per week, and found that metastatic lesions in the LUNG and liver of a man with a primary renal cell carcinoma disappeared in a matter of weeks (1). At that time we believed IAA was useful for patients with cancer solely through two biological response modifier mechanisms: increased production of extracellular collagen ("walling off' the tumor as proposed by Cameron and Pauling) and enhancement of immune function. We subsequently reported a case of resolution of bone metastases in a patient with primary breast cancer (1A) using infusions of 100 grams, once or twice per week (2).
In a recent publication (3) we presented evidence that ascorbic acid and its salts (AA) could be more than biological response modifiers. We found that ascorbic acid is preferentially toxic to tumor cells suggesting that it could be useful as a chemotherapeutic agent. Preferential toxicity occurred in vitro in multiple tumor cell types. We also presented data suggesting that plasma concentrations of ascorbate required for killing tumor cells were achievable in humans. Others have described in vivo toxicity in multiple tumor types and animal models (4-8).

Addendum & caveat by Healing Cancer Naturally

1 Reportedly, megadoses of intravenous vitamin C will deplete copper so it's important to keep adequate levels of this mineral in the blood to avoid potentially serious consequences in people whose health is already strongly compromised.
2 Physician Dr. Riordan includes in his IV Vitamin C treatment protocol a test for a possible (although rare) G6PD (glucose-6-phosphate dehydrogenase) enzyme deficiency. If this enzyme (which is required for the integrity of red blood cell membranes) is lacking, vitamin C megadoses can induce hemolysis.
* Please note that the vitamin C referred to in the article is a man-made substance called ascorbic acid not fully identical with the vitamin C as found in natural foods. On the other hand, the vitamincfoundation.org quite convincingly argues to the contrary. You decide.

**http://www.healingcancernaturally.com/vitamin-c-cancer-therapy-cure.html sitesinden alınmıştır

Mevcut yazılı metin bilgilendirme amaçlıdır. Bilimsel verilerden elde edilmiş bilgilerdir. Konu hakkında uzman kişiler tarafından yönlendirilmeniz ve tedaviye yönelik işlemleri bir hekim kontrolünde uygulamanız veya uygulatmanız önerilir.Ankara ozon , ozon ankara , alternatif kanser tedavisi , dmso , integratif tıp , akupunktur ,

20 Ağustos 2015 Perşembe

OZON TEDAVİSİNİN PROSTAT KANSERLİ HASTALARDA RADYOTERAPİYE BAĞLI REKTAL KANAMALARDAKİ ETKİLERİ


Research Article
Ozone Therapy in the Management of Persistent
Radiation-Induced Rectal Bleeding in Prostate Cancer Patients
Bernardino Clavo,1,2,3,4,5 Norberto Santana-Rodriguez,3,4 Pedro Llontop,3
Dominga Gutierrez,1,4 Daniel Ceballos,6 Charlin Méndez,3 Gloria Rovira,7
Gerardo Suarez,1,4 Dolores Rey-Baltar,1,4 Laura Garcia-Cabrera,1
Gregorio Martínez-Sánchez,8 and Dolores Fiuza3


1Radiation Oncology, Dr. Negrin University Hospital, 35.010 Las Palmas, Spain
2Chronic Pain, Dr. Negrin University Hospital, 35.010 Las Palmas, Spain
3Experimental Surgery-Research Unit, Dr. Negrin University Hospital, 35.010 Las Palmas, Spain
4Canary Islands Institute for Cancer Research (ICIC), 35.010 Las Palmas, Spain
5Spanish Group for Clinical Research in Radiation Oncology (GICOR), Madrid, Spain
6Gastroenterology, Dr. Negrin University Hospital, 35.010 Las Palmas, Spain
7Ozone Therapy Unit, Quiron Hospital, 08.023 Barcelona, Spain
8Medical Center Beauty Benefit-San Biagio di Osimo, Osimo, 60.027 Ancona, Italy


Correspondence should be addressed to Bernardino Clavo; bernardinoclavo@gmail.com
Received 21 May 2015; Revised 24 June 2015; Accepted 30 June 2015
Academic Editor: Olumayokun A. Olajide
Copyright © 2015 Bernardino Clavo et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.



Introduction. Persistent radiation-induced proctitis and rectal bleeding are debilitating complications with limited therapeutic options. We present our experience with ozone therapy in the management of such refractory rectal bleeding. Methods. Patients (� = 12) previously irradiated for prostate cancer with persistent or severe rectal bleeding without response to conventional treatment were enrolled to receive ozone therapy via rectal insufflations and/or topical application of ozonized-oil. Ten (83%) patients had Grade 3 or Grade 4 toxicity. Median follow-up after ozone therapy was 104 months (range: 52–119). Results. Following ozone therapy, the median grade of toxicity improved from 3 to 1 (� < 0.001) and the number of endoscopy treatments from 37 to 4 (� = 0.032). Hemoglobin levels changed from 11.1 (7–14) g/dL to 13 (10–15) g/dL, before and after ozone therapy, respectively (� = 0.008). Ozone therapy was well tolerated and no adverse effects were noted, except soft and temporary flatulence for some hours after each session. Conclusions. Ozone therapy was effective in radiation-induced rectal bleeding in prostate cancer patients without serious adverse events. It proved useful in the management of rectal bleeding and merits further evaluation.

References
[1] K. S. Choe, A. B. Jani, and S. L. Liauw, “External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 3, pp. 755–760, 2010.
[2] R. Stacey and J. T. Green, “Nonendoscopic therapies for the management of radiation-induced rectal bleeding,” Current Opinion in Supportive and Palliative Care, vol. 7, no. 2, pp. 175–182, 2013.
[3] A. Zapatero, A. Guerrero, X. Maldonado et al., “High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial,” The Lancet Oncology, vol. 16, no. 3, pp. 320–327, 2015.
[4] S. T. H. Peeters, W. D. Heemsbergen, P. C. M. Koper et al.,“Dose-respo nse in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy,” Journal of Clinical Oncology, vol. 24, no. 13, pp. 1990–1996, 2006.
[5] M. J. Zelefsky, Y. Yamada, X. Pei et al., “Comparison of tumor control and toxicity outcomes of high-dose intensitymodulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer,” Urology, vol. 77, no. 4, pp. 986–
993, 2011.
[6] R. K. Nam, P. Cheung, S. Herschorn et al., “Incidence of complications other than urinary incontinence or erectile dysfunction
after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study,” The Lancet Oncology, vol. 15,
no. 2, pp. 223–231, 2014.
[7] R. E. Clarke, L. M. Tenorio, J. R. Hussey et al., “Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a
randomized and controlled double-blind crossover trial with long-term follow-up,” International Journal of Radiation Oncology, Biology, Physics, vol. 72, no. 1, pp. 134–143, 2008.
[8] M. L. Rodr´ ıguez, M. M. Mart´ ın, L. C. Padellano, A. M. Palomo, and Y. I. Puebla, “Gastrointestinal toxicity associated
to radiation therapy,” Clinical and Translational Oncology, vol. 12, no. 8, pp. 554–561, 2010.
[9] K. M. Greven and T. Paunesku, “Radiation complications of the pelvis,” in Radiation Toxicity: A Practical Guide, W. J. Samll and
G. E. Woloschak, Eds., pp. 125–153, Springer Science+Business Media, New York, NY, USA, 2008.
[10] V. Bocci, E. Borrelli, V. Travagli, and I. Zanardi, “The ozone paradox: ozone is a strong oxidant as well as a medical drug,”
Medicinal Research Reviews, vol. 29, no. 4, pp. 646–682, 2009.

[11] G. Stoker, “The surgical uses of ozone,” The Lancet, vol. 26, p. 797, 1917.
[12] B. Clavo, D. Gutierrez, D. Mart ´ ´ ın, G. Suarez, M. A. Hern ´ andez, ´and F. Robaina, “Intravesical ozone therapy for progressive
radiation-induced hematuria,” Journal of Alternative and Complementary Medicine, vol. 11, no. 3, pp. 539–541, 2005.
[13] B. Clavo, N. Santana-Rodriguez, S. M. Lopez-Silva et al., “Per- ´sistent PORT-A-CATH-related fistula and fibrosis in a breast
cancer patient successfully treated with local ozone application,”Journal of Pain and Symptom Management, vol. 43, no. 2, pp. e3–
e6, 2012.
[14] B. Clavo, D. Ceballos, D. Gutierrez et al., “Long-term control of refractory hemorrhagic radiation proctitis with ozone therapy,”
Journal of Pain and Symptom Management, vol. 46, no. 1, pp. 106–112, 2013.
[15] B. Clavo, G. Suarez, Y. Aguilar et al., “Brain ischemia and hypometabolism treated by ozone therapy,” Forschende Komplementarmedizin ¨ , vol. 18, no. 5, pp. 283–287, 2011.

[16] National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) grading system (version 4.0), http://
evs.nci.nih.gov/ftp1/CTCAE/CTCAE 4.03 2010-06-14 QuickReference 5x7.pdf.
[17] The International Scientific Committee of Ozone Therapy, “Madrid declaration on ozone therapy,” http://www.aepromo .org/declaracion madrid/Madrid declaration.pdf.
[18] V. A. Bocci, I. Zanardi, and V. Travagli, “Ozone acting on human blood yields a hormetic dose-response relationship,” Journal of
Translational Medicine, vol. 9, article 66, 2011.
[19] R. Kochhar, F. Patel, S. C. Sharma et al., “Radiation-induced proctosigmoiditis—prospective, randomized, double-blind
controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate,” Digestive Diseases and Sciences, vol. 36, no. 1,
pp. 103–107, 1991.
[20] A. Hille, M. K. A. Herrmann, T. Kertesz et al., “Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in
patients with prostate cancer and the impact on late proctitis: a prospective evaluation,” Strahlentherapie und Onkologie, vol.
184, no. 12, pp. 686–692, 2008.
[21] D. M. Jensen, G. A. Machicado, S. Cheng, M. E. Jensen, and R. Jutabha, “A randomized prospective study of endoscopic bipolar electrocoagulation and heater probe treatment of chronic rectal bleeding from radiation telangiectasia,” Gastrointestinal Endoscopy, vol. 45, no. 1, pp. 20–25, 1997.
[22] G. Karamanolis, K. Triantafyllou, Z. Tsiamoulos et al., “Argon plasma coagulation has a long-lastingtherapeutic effect in patients with chronic radiation proctitis,” Endoscopy, vol. 41, no. 6, pp. 529–531, 2009.
[23] E. M. Haas, H. R. Bailey, and I. Farragher, “Application of 10 percent formalin for the treatment of radiation-induced hemorrhagic proctitis,” Diseases of the Colon and Rectum, vol. 50, no. 2, pp. 213–217, 2007.
[24] R. Mayer, H. Klemen, F. Quehenberger et al., “Hyperbaric oxygen—an effective tool to treat radiation morbidity in prostate cancer,” Radiotherapy and Oncology, vol. 61, no. 2, pp.151–156, 2001 .
[25] G. Karamanolis, P. Psatha, and K. Triantafyllou, “Endoscopic
treatments for chronic radiation proctitis,” World Journal of
Gastrointestinal Endoscopy, vol. 5, no. 7, pp. 308–312, 2013.
[26] M. Hauer-Jensen, J. Wang, and J. W. Denham, “Bowel injury:
current and evolving management strategies,” Seminars in
Radiation Oncology, vol. 13, no. 3, pp. 357–371, 2003.
[27] R. Giunta, A. Coppola, C. Luongo et al., “Ozonized autohemotransfusion improves hemorheological parameters and oxygen
delivery to tissues in patients with peripheral occlusive arterial disease,” Annals of Hematology, vol. 80, no. 12, pp. 745–748, 2001.
[28] B. Clavo, L. Catala, J. L. Perez, V. Rodriguez, and F. Robaina, “Ozone therapy on cerebral blood flow: a preliminary report,”
Evidence-Based Complementary and Alternative Medicine 7 Evidence-Based Complementary and Alternative Medicine, vol.
1, no. 3, pp. 315–319, 2004.
[29] B. Clavo, D. Fiuza, F. Robaina et al., “Effect of ozone therapy on muscle oxygenation,” Journal of Alternative and Complementary
Medicine, vol. 9, no. 2, pp. 251–256, 2003.
[30] L. Re, G. Malcangi, and G. MartinezSanchez, “Medical ozone is now ready for a scientific challenge: current status and future
perspectives,” Journal of Experimental and Integrative Medicinevol. 2, pp. 193–196, 2012.
[31] A. Pecorelli, V. Bocci, A. Acquaviva et al., “NRF2 activation is involved in ozonated human serum upregulation of HO-1 in
endothelial cells,” Toxicology and Applied Pharmacology, vol. 267, no. 1, pp. 30–40, 2013.
[32] L. Re, G. Mart´ ınez-Sanchez, M. Bordicchia et al., “Is ozone pre- ´conditioning effect linked to Nrf2/EpRE activation pathway in
vivo? A preliminary result,” European Journal of Pharmacology,
vol. 742, pp. 158–162, 2014.
[33] V. Bocci and G. Valacchi, “Nrf2 activation as target to implement therapeutic treatments,” Frontiers in Chemistry, vol. 3,
article 4, 2015.
[34] V. Bocci, Ozone. A New Medical Drug, Springer, Dordrecht, The Netherlands, 2nd edition, 2011.
[35] M. Sagai and V. Bocci, “Mechanisms of Action Involved in Ozone Therapy: is healing induced via a mild oxidative stress?”
Medical Gas Research, vol. 1, no. 1, p. 29, 2011.
[36] M. Kennedy, K. Bruninga, E. A. Mutlu, J. Losurdo, S. Choudhary, and A. Keshavarzian, “Successful and sustained treatment
of chronic radiation proctitis with antioxidant vitamins E and
C,” The American Journal of Gastroenterology, vol. 96, no. 4, pp.
1080–1084, 2001.
[37] A. Hille, H. Christiansen, O. Pradier et al., “Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis,” Strahlentherapie und Onkologie, vol. 181, no. 9, pp. 606–614, 2005.
[38] G. Valacchi, Y. Lim, G. Belmonte et al., “Ozonated sesame oil enhances cutaneous wound healing in SKH1 mice,” Wound
Repair and Regeneration, vol. 19, no. 1, pp. 107–115, 2011.
[39] G. Mart´ ınez-Sanchez, L. Re, G. Perez-Davison, and R. Horwat- ´Delaporte, “Las aplicaciones medicas de los aceites ozonizados, ´
actualizacion,” ´ Revista Espanola de Ozonoterapia ˜ , vol. 2, no. 1, pp. 121–139, 2012.
[40] F. A. Gultekin, B. H. Bakkal, D. S ¨ umer, F. K ¨ okt ¨ urk, and S. Bektas ¨ ¸, “Effects of ozonated olive oil on acute radiation proctitis in rats,” Balkan Medical Journal, vol. 30, no. 4, pp. 369–374, 2013.
[41] A. Agrillo, F. Filiaci, V. Ramieri et al., “Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the
treatment of 131 cases with ozone therapy,” European Review for Medical and Pharmacological Sciences, vol. 16, no. 12, pp. 1741–
1747, 2012.
[42] C. I. Ripamonti, E. Cislaghi, L. Mariani, and M. Maniezzo,“ Efficacy and safety of medical ozone (O3) delivered in oil
suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: preliminary results of a phase I-II study,” Oral Oncologyvol. 47, no. 3, pp. 185–190, 2011.
[43] J. Cavcic, J. Turcic, P. Martinac et al., “Metronidazole in the treatment of chronic radiation proctitis: clinical trial,” Croatian
Medical Journal, vol. 41, no. 3, pp. 314–318, 2000.

AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s
Disease
Evidence-Based
Complementary and
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com

Mevcut yazılı metin bilgilendirme amaçlıdır. Bilimsel verilerden elde edilmiş bilgilerdir. Konu hakkında uzman kişiler tarafından yönlendirilmeniz ve tedaviye yönelik işlemleri bir hekim kontrolünde uygulamanız veya uygulatmanız önerilir.Ankara ozon , ozon ankara , alternatif kanser tedavisi , dmso , integratif tıp , akupunktur ,